X

The Wait is Over - Nobel Prize for Medicine 2011 Announced

by Dr. Reeja Tharu on  October 03, 2011 at 7:21 PM Health Watch   - G J E 4
A -A +
The announcement for the coveted Nobel Prizes have begun. As expected, the American scientist rule the roost!
 The Wait is Over - Nobel Prize for Medicine 2011 Announced
The Wait is Over - Nobel Prize for Medicine 2011 Announced

This year, one half of the Nobel for Medicine has gone to Bruce A. Beutler and Jules A. Hoffmann "for their discoveries concerning the activation of innate immunity." They discovered proteins that could identify micro organisms and activate innate immunity. This is the first step towards an immune response.

The other half of the prize has gone t to Ralph M. Steinman "for his discovery of the dendritic cell and its role in adaptive immunity."  Steinman discovered the dendritic cells of the immune system and studied their role in adaptive immunity which is actually a later- stage  immune response.

From Fundamental Research to Medical Use


The discoveries that are awarded the 2011 Nobel Prize have provided novel insights into the activation and regulation of our immune system. They have made possible the development of new methods for preventing and treating disease, for instance with improved vaccines against infections and in attempts to stimulate the immune system to attack tumors. These discoveries also help us understand why the immune system can attack our own tissues, thus providing clues for novel treatment of inflammatory diseases.

Bruce A. Beutler was born in 1957 in Chicago, USA. He received his MD from the University of Chicago in 1981 and worked as a scientist at Rockefeller University in New York and the University of Texas in Dallas, where he discovered the LPS receptor. Since 2000 he has been professor of genetics and immunology at The Scripps Research Institute, La Jolla, USA.

Jules A. Hoffmann was born in Echternach, Luxembourg in 1941. He studied at the University of Strasbourg in France, where he obtained his PhD in 1969. After postdoctoral training at the University of Marburg, Germany, he returned to Strasbourg, where he headed a research laboratory from 1974 to 2009. He has also served as director of the Institute for Molecular Cell Biology in Strasbourg and during 2007-2008 as President of the French National Academy of Sciences.

Ralph M. Steinman was born in 1943 in Montreal, Canada, where he studied biology and chemistry at McGill University. After studying medicine at Harvard Medical School in Boston, MA, USA, he received his MD in 1968. He has been affiliated with Rockefeller University in New York since 1970, has been professor of immunology at this institution since 1988, and is also director of its Center for Immunology and Immune Diseases.

Scientists have long been searching for the gatekeepers of the immune response by which man and other animals defend themselves against attack by bacteria and other microorganisms. Bruce Beutler and Jules Hoffmann discovered receptor proteins that can recognize such microorganisms and activate innate immunity, the first step in the body's immune response. Ralph Steinman discovered the dendritic cells of the immune system and their unique capacity to activate and regulate adaptive immunity, the later stage of the immune response during which microorganisms are cleared from the body.

The discoveries of the three Nobel Laureates have revealed how the innate and adaptive phases of the immune response are activated and thereby provided novel insights into disease mechanisms. Their work has opened up new avenues for the development of prevention and therapy against infections, cancer, and inflammatory diseases.

Two Lines of Defense In The Immune System

We live in a dangerous world. Pathogenic microorganisms (bacteria, virus, fungi, and parasites) threaten us continuously but we are equipped with powerful defense mechanisms (please see image below). The first line of defense, innate immunity, can destroy invading microorganisms and trigger inflammation that contributes to blocking their assault. If microorganisms break through this defense line, adaptive immunity is called into action. With its T and B cells, it produces antibodies and killer cells that destroy infected cells. After successfully combating the infectious assault, our adaptive immune system maintains an immunologic memory that allows a more rapid and powerful mobilization of defense forces next time the same microorganism attacks. These two defense lines of the immune system provide good protection against infections but they also pose a risk. If the activation threshold is too low, or if endogenous molecules can activate the system, inflammatory disease may follow.

The components of the immune system have been identified step by step during the 20thcentury. Thanks to a series of discoveries awarded the Nobel Prize, we know, for instance, how antibodies are constructed and how T cells recognize foreign substances. However, until the work of Beutler, Hoffmann and Steinman, the mechanisms triggering the activation of innate immunity and mediating the communication between innate and adaptive immunity remained enigmatic.

Discovering the Sensors of Innate Immunity

Jules Hoffmann made his pioneering discovery in 1996, when he and his co-workers investigated how fruit flies combat infections. They had access to flies with mutations in several different genes including Toll, a gene previously found to be involved in embryonal development by Christiane Nüsslein-Volhard (Nobel Prize 1995). When Hoffmann infected his fruit flies with bacteria or fungi, he discovered that Toll mutants died because they could not mount an effective defense. He was also able to conclude that the product of the Toll gene was involved in sensing pathogenic microorganisms and Toll activation was needed for successful defense against them.

Bruce Beutler was searching for a receptor that could bind the bacterial product, lipopolysaccharide (LPS), which can cause septic shock, a life threatening condition that involves overstimulation of the immune system. In 1998, Beutler and his colleagues discovered that mice resistant to LPS had a mutation in a gene that was quite similar to the Toll gene of the fruit fly. This Toll-like receptor (TLR) turned out to be the elusive LPS receptor. When it binds LPS, signals are activated that cause inflammation and, when LPS doses are excessive, septic shock. These findings showed that mammals and fruit flies use similar molecules to activate innate immunity when encountering pathogenic microorganisms. The sensors of innate immunity had finally been discovered.

The discoveries of Hoffmann and Beutler triggered an explosion of research in innate immunity. Around a dozen different TLRs have now been identified in humans and mice. Each one of them recognizes certain types of molecules common in microorganisms. Individuals with certain mutations in these receptors carry an increased risk of infections while other genetic variants of TLR are associated with an increased risk for chronic inflammatory diseases.

A new cell type that controls adaptive immunity

Ralph Steinman discovered, in 1973, a new cell type that he called the dendritic cell. He speculated that it could be important in the immune system and went on to test whether dendritic cells could activate T cells, a cell type that has a key role in adaptive immunity and develops an immunologic memory against many different substances. In cell culture experiments, he showed that the presence of dendritic cells resulted in vivid responses of T cells to such substances. These findings were initially met with skepticism but subsequent work by Steinman demonstrated that dendritic cells have a unique capacity to activate T cells.

Further studies by Steinman and other scientists went on to address the question of how the adaptive immune system decides whether or not it should be activated when encountering various substances. Signals arising from the innate immune response and sensed by dendritic cells were shown to control T cell activation. This makes it possible for the immune system to react towards pathogenic microorganisms while avoiding an attack on the body's own endogenous molecules.

Analysts  have been able to predict the award outcomes rather precisely for several years. The Nobel world was originally dominated by the Europeans—the British, Germans and the French-- and it was only after the World War II that the Americans began to emerge as the world leaders in the field of science, technology and economics.

Predicting Nobel prizes is easy and difficult at the same time. The analysts mainly concentrate on the "most cited" researchers the world over. This is usually dominated by the Americans. Once the scientists are narrowed down it becomes harder to predict the winner. But, of late, America's investment in physical sciences is not as much as before, therefore it is predicted  that some  Asian countries, such as China, will enter the fray and  give the Americans a run for their money.

The tissue engineering team from the Boston, USA-- Robert Langer and Joseph Vacanti—were those tipped to be prize winners this year. Others expected to win include Sajeev John(Toronto, Canada) and Eli Yablonovitch (Berkeley, California) for their impressive work on photonics, and Allen Bard (Austin, Texas) for his research  on scanning electrochemical microscopy.

Nobel prize for medicine is the first to be  announced . The announcement for the prize for Medicine  will be followed by announcement for Physics, chemistry, economics and literature. The Nobel prize carry a worth of one million dollars and a maximum of  three individuals are allowed to share the prize.

More News on:

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
The sad part is Ralph Steinman died before the award was announced.
Indian01 Tuesday, October 04, 2011

Most Popular News on Medindia

P
M
X

Ask an Expert

Ask an Expert+
s
Cancer Fighting “Super Broccoli” in UK Markets
 Cancer Fighting “Super Broccoli” in UK Markets
S  Like Yourself or Others: It may be in Your Genes
Like Yourself or Others: It may be in Your Genes